Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
South Korea
· Delayed Price · Currency is KRW 29,000
+50 (0.17%)
Apr 29, 2026, 3:30 PM KST
Daihan Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 170,226 | 171,990 | 154,056 | 163,170 | 183,600 | 172,200 | Upgrade
|
| Market Cap Growth | 13.98% | 11.64% | -5.59% | -11.13% | 6.62% | -12.90% | Upgrade
|
| Enterprise Value | 80,704 | 85,789 | 80,167 | 60,093 | 96,028 | 117,564 | Upgrade
|
| Last Close Price | 28950.00 | 29250.00 | 25333.88 | 25919.62 | 27814.69 | 25531.67 | Upgrade
|
| PE Ratio | 6.16 | 6.22 | 4.56 | 5.74 | 7.36 | 7.60 | Upgrade
|
| PS Ratio | 0.82 | 0.82 | 0.75 | 0.83 | 1.00 | 1.00 | Upgrade
|
| PB Ratio | 0.57 | 0.57 | 0.56 | 0.66 | 0.82 | 0.85 | Upgrade
|
| P/TBV Ratio | 0.57 | 0.57 | 0.56 | 0.66 | 0.82 | 0.85 | Upgrade
|
| P/FCF Ratio | 353.51 | 357.17 | 7.76 | 9.28 | 9.01 | 5.99 | Upgrade
|
| P/OCF Ratio | 6.65 | 6.72 | 4.32 | 4.20 | 6.33 | 4.24 | Upgrade
|
| EV/Sales Ratio | 0.39 | 0.41 | 0.39 | 0.31 | 0.52 | 0.69 | Upgrade
|
| EV/EBITDA Ratio | 2.00 | 2.12 | 1.77 | 1.35 | 2.28 | 2.90 | Upgrade
|
| EV/EBIT Ratio | 2.59 | 2.75 | 2.11 | 1.68 | 2.91 | 4.04 | Upgrade
|
| EV/FCF Ratio | 167.60 | 178.16 | 4.04 | 3.42 | 4.71 | 4.09 | Upgrade
|
| Debt / Equity Ratio | 0 | 0 | 0 | - | 0.03 | 0.12 | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | 0.00 | 0.00 | - | 0.15 | 0.58 | Upgrade
|
| Debt / FCF Ratio | 0.03 | 0.03 | 0.00 | - | 0.32 | 0.82 | Upgrade
|
| Net Debt / Equity Ratio | -0.30 | -0.30 | -0.28 | -0.42 | -0.40 | -0.36 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.22 | -2.22 | -1.70 | -2.35 | -2.16 | -1.80 | Upgrade
|
| Net Debt / FCF Ratio | -185.91 | -185.91 | -3.89 | -5.94 | -4.47 | -2.53 | Upgrade
|
| Asset Turnover | 0.62 | 0.62 | 0.66 | 0.69 | 0.67 | 0.65 | Upgrade
|
| Inventory Turnover | 4.75 | 4.75 | 5.36 | 5.38 | 5.46 | 5.22 | Upgrade
|
| Quick Ratio | 2.84 | 2.84 | 2.58 | 3.28 | 3.04 | 2.72 | Upgrade
|
| Current Ratio | 3.64 | 3.64 | 3.22 | 3.87 | 3.65 | 3.20 | Upgrade
|
| Return on Equity (ROE) | 9.59% | 9.59% | 12.89% | 12.01% | 11.66% | 11.79% | Upgrade
|
| Return on Assets (ROA) | 5.80% | 5.80% | 7.69% | 7.83% | 7.50% | 6.91% | Upgrade
|
| Return on Invested Capital (ROIC) | 12.45% | 12.70% | 17.74% | 19.93% | 18.62% | 15.86% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.30% | 10.30% | 13.50% | 14.20% | 14.10% | 12.80% | Upgrade
|
| Earnings Yield | 16.24% | 16.07% | 21.91% | 17.42% | 13.59% | 13.16% | Upgrade
|
| FCF Yield | 0.28% | 0.28% | 12.88% | 10.77% | 11.10% | 16.71% | Upgrade
|
| Payout Ratio | 18.79% | 18.79% | 12.82% | 13.20% | 8.45% | 9.30% | Upgrade
|
| Buyback Yield / Dilution | - | - | - | 1.75% | 0.25% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.